HJB Pharma-B (02142) has announced that Qiu Jiaci has resigned from his position as an independent non-executive director and chairman of the board's audit committee and a member of the board's remuneration committee. After he resigned from his positions, (i) Ye Xiaoping, an independent non-executive director, was appointed as the chairman of the audit committee and a member of the remuneration committee, and (ii) Albert R. Collinson, an independent non-executive director, was appointed as a member of the audit committee and chairman of the remuneration committee, effective June 21, 2024.
According to the announcement made by HJB Pharma-B (02142), Qiu Jiaci has resigned from his position as an independent non-executive director, chairman of the board's audit committee, and a member of the board's remuneration committee, effective June 21, 2024, as he wants to devote more time to his personal career.
After the resignation, (i) Ye Xiaoping, an independent non-executive director, was appointed as chairman of the audit committee and a member of the remuneration committee, and (ii) Albert R. Collinson, an independent non-executive director, was appointed as a member of the audit committee and chairman of the remuneration committee, effective June 21, 2024.